Lipid Nanoparticle: Beyond Delivery Vehicle—Unveiling Its Immunological Adjuvant Potential
The FASEB Journal · 31.05.2025 · 39 (10)
DOI: 10.1096/fj.202500622r ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 15.05.2025. Verfasst von Narh Philip Amor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Center for Nucleic Acid Medicine, Institute for Innovative Drug Development and Life Sciences, Wuxi, China Pharmaceutical University, Nanj…. Hauptthemen laut MEDLINE: Adjuvants, Immunologic, Nanoparticles, Lipids, Drug Delivery Systems. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) have extensively been used in drug delivery over the years, and the perspective of their significance has been well established. Latest findings have demonstrated the inherent adjuvant capacity of some specific lipid components, especially in stimulating immune compartments, which prompted the rational use of lipid‐based delivery vehicles in drug R&D. In this concise review, we summarize current knowledge on the adjuvant properties of LNP, with a particular focus on the key components that mediate such effects. Specifically, we describe the vital role of ionizable lipids in triggering innate immune activation and inflammation and highlight the importance of these lipids in determining vaccine effectiveness or safety. Furthermore, the mechanisms by which LNP enhance the immune response are discussed in detail, shedding light on their potential applications in next‐generation vaccine design and development. We also present compelling pre‐clinical studies that serve as strong evidence for the adjuvant properties of LNP components in enhancing vaccine immunogenicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Innovation Center for Nucleic Acid Medicine, Institute for Innovative Drug Development and Life Sciences, Wuxi, China Pharmaceutical University, Nanjing, China.
- Institute of Translational Medicine, China Pharmaceutical University, Nanjing, China.
- Center for Infectious Medicine and Vaccine Research, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
- Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China.
- Institute of Veterinary Medicine, Xinjiang Academy of Animal Sciences, Urumqi, China.
- Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation of China
Zitieren
APA
Amor, N. P., Guo, K., Zhang, S., Xia, J., Yang, Y., & Lin, A. (2025). Lipid Nanoparticle: Beyond Delivery Vehicle—Unveiling Its Immunological Adjuvant Potential. The FASEB Journal, 39(10). https://doi.org/10.1096/fj.202500622r
Vancouver
Amor NP, Guo K, Zhang S, Xia J, Yang Y, Lin A. Lipid Nanoparticle: Beyond Delivery Vehicle—Unveiling Its Immunological Adjuvant Potential. The FASEB Journal. 2025;39(10). doi:10.1096/fj.202500622r
BibTeX
@article{Amor2025,
author = {Amor, Narh Philip and Guo, Kun and Zhang, Shun and Xia, Jun and Yang, Yong and Lin, Ang},
title = {Lipid Nanoparticle: Beyond Delivery Vehicle—Unveiling Its Immunological Adjuvant Potential},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {10},
doi = {10.1096/fj.202500622r}
}
EUVIMED